Annual Accounts Receivable
$6.55 M
+$474.00 K+7.80%
31 December 2023
Summary:
Exagen annual accounts receivable is currently $6.55 million, with the most recent change of +$474.00 thousand (+7.80%) on 31 December 2023. During the last 3 years, it has fallen by -$3.10 million (-32.14%). XGN annual accounts receivable is now -32.14% below its all-time high of $9.65 million, reached on 31 December 2021.XGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$9.39 M
-$2.32 M-19.79%
30 September 2024
Summary:
Exagen quarterly accounts receivable is currently $9.39 million, with the most recent change of -$2.32 million (-19.79%) on 30 September 2024. Over the past year, it has increased by +$2.84 million (+43.29%). XGN quarterly accounts receivable is now -44.92% below its all-time high of $17.04 million, reached on 30 September 2023.XGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XGN Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +43.3% |
3 y3 years | -32.1% | -2.8% |
5 y5 years | +14.6% | +64.3% |
XGN Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -32.1% | +7.8% | -44.9% | +54.5% |
5 y | 5 years | -32.1% | +14.6% | -44.9% | +64.3% |
alltime | all time | -32.1% | -44.9% |
Exagen Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $9.39 M(-19.8%) |
June 2024 | - | $11.70 M(+7.4%) |
Mar 2024 | - | $10.90 M(+66.4%) |
Dec 2023 | $6.55 M(+7.8%) | $6.55 M(-61.6%) |
Sept 2023 | - | $17.04 M(+5.0%) |
June 2023 | - | $16.23 M(+74.5%) |
Mar 2023 | - | $9.30 M(+53.1%) |
Dec 2022 | $6.08 M(-37.1%) | $6.08 M(-42.9%) |
Sept 2022 | - | $10.64 M(+10.9%) |
June 2022 | - | $9.59 M(-12.1%) |
Mar 2022 | - | $10.91 M(+13.0%) |
Dec 2021 | $9.65 M(+8.4%) | $9.65 M(+4.8%) |
Sept 2021 | - | $9.21 M(+4.9%) |
June 2021 | - | $8.78 M(+6.8%) |
Mar 2021 | - | $8.22 M(-7.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $8.91 M(+55.9%) | $8.91 M(-4.2%) |
Sept 2020 | - | $9.30 M(+28.0%) |
June 2020 | - | $7.26 M(+24.3%) |
Mar 2020 | - | $5.84 M(+2.2%) |
Dec 2019 | $5.71 M(-4.0%) | $5.71 M(-8.4%) |
Sept 2019 | - | $6.24 M(-7.4%) |
June 2019 | - | $6.73 M(+13.1%) |
Dec 2018 | $5.95 M(+885.4%) | $5.95 M(>+9900.0%) |
Dec 2017 | $604.00 K(+1018.5%) | - |
Sept 2015 | - | $0.00(0.0%) |
June 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Sept 2014 | - | $0.00(0.0%) |
June 2014 | - | $0.00(-100.0%) |
Dec 2013 | $54.00 K(>+9900.0%) | $54.00 K |
Dec 2012 | $0.00 | - |
FAQ
- What is Exagen annual accounts receivable?
- What is the all time high annual accounts receivable for Exagen?
- What is Exagen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Exagen?
- What is Exagen quarterly accounts receivable year-on-year change?
What is Exagen annual accounts receivable?
The current annual accounts receivable of XGN is $6.55 M
What is the all time high annual accounts receivable for Exagen?
Exagen all-time high annual accounts receivable is $9.65 M
What is Exagen quarterly accounts receivable?
The current quarterly accounts receivable of XGN is $9.39 M
What is the all time high quarterly accounts receivable for Exagen?
Exagen all-time high quarterly accounts receivable is $17.04 M
What is Exagen quarterly accounts receivable year-on-year change?
Over the past year, XGN quarterly accounts receivable has changed by +$2.84 M (+43.29%)